CoverageForm 410-K10-Q8-K13D13G13F

Kumar Neil

CIK 0001742485
Chief Executive OfficerDirector

Filings

50

Latest May 26, 2026

Issuers covered

2

Showing

50 of 50

Page 1

Track record

132 of 149 open-market trades scored (89% price coverage) - 17 issuers without price data. Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).

HorizonTradesWin rateAvgMedianBestWorst
30 days13242%-6.1%-4.5%+14.4%-52.4%
90 days11439%-15.5%-5.3%+11.2%-138.0%
180 days8312%-38.8%-30.7%+14.6%-194.7%
365 days2612%-115.7%-95.9%+23.6%-390.8%

Issuers

Companies where Kumar Neil has filed

TickerIssuerFilingsLast filed
BBIOBridgebio Pharma, Inc.49May 26, 2026
MAZEMaze Therapeutics, Inc.1Mar 31, 2026

All filings

50 Form 4 / 4-A filings, newest first

Sign in to download
Filed Top transactionSharesPriceValue